全文获取类型
收费全文 | 1154篇 |
免费 | 0篇 |
专业分类
系统科学 | 13篇 |
教育与普及 | 2篇 |
理论与方法论 | 18篇 |
现状及发展 | 444篇 |
研究方法 | 176篇 |
综合类 | 495篇 |
自然研究 | 6篇 |
出版年
2018年 | 10篇 |
2017年 | 12篇 |
2016年 | 11篇 |
2014年 | 14篇 |
2013年 | 10篇 |
2012年 | 61篇 |
2011年 | 76篇 |
2010年 | 26篇 |
2009年 | 7篇 |
2008年 | 45篇 |
2007年 | 56篇 |
2006年 | 59篇 |
2005年 | 58篇 |
2004年 | 29篇 |
2003年 | 31篇 |
2002年 | 41篇 |
2001年 | 35篇 |
2000年 | 43篇 |
1999年 | 39篇 |
1992年 | 31篇 |
1991年 | 11篇 |
1990年 | 9篇 |
1989年 | 10篇 |
1988年 | 11篇 |
1987年 | 19篇 |
1986年 | 15篇 |
1985年 | 27篇 |
1984年 | 15篇 |
1983年 | 13篇 |
1982年 | 8篇 |
1981年 | 9篇 |
1980年 | 11篇 |
1979年 | 23篇 |
1978年 | 18篇 |
1977年 | 13篇 |
1976年 | 11篇 |
1975年 | 13篇 |
1974年 | 13篇 |
1973年 | 14篇 |
1972年 | 21篇 |
1971年 | 19篇 |
1970年 | 15篇 |
1969年 | 14篇 |
1968年 | 18篇 |
1967年 | 15篇 |
1966年 | 10篇 |
1965年 | 9篇 |
1964年 | 12篇 |
1956年 | 6篇 |
1947年 | 4篇 |
排序方式: 共有1154条查询结果,搜索用时 15 毫秒
51.
52.
Vissers LE van Ravenswaaij CM Admiraal R Hurst JA de Vries BB Janssen IM van der Vliet WA Huys EH de Jong PJ Hamel BC Schoenmakers EF Brunner HG Veltman JA van Kessel AG 《Nature genetics》2004,36(9):955-957
CHARGE syndrome is a common cause of congenital anomalies affecting several tissues in a nonrandom fashion. We report a 2.3-Mb de novo overlapping microdeletion on chromosome 8q12 identified by array comparative genomic hybridization in two individuals with CHARGE syndrome. Sequence analysis of genes located in this region detected mutations in the gene CHD7 in 10 of 17 individuals with CHARGE syndrome without microdeletions, accounting for the disease in most affected individuals. 相似文献
53.
54.
55.
56.
J. Dogterom Tj. B. van Wimersma Greidanus D. De Wied 《Cellular and molecular life sciences : CMLS》1976,32(5):659-660
Summary Intraperitoneal and intraventricular injection of histamine induces a very fast and high elevation of vasopressin in rat plasma as determined by radioimmunoassay. The effects are dose and time related. The intraventricular injection is more effective with regard to time and dose than the intraperitoneal injection. 相似文献
57.
van den Bergh S 《Nature》1971,231(5297):35-36
58.
59.
60.
Meijers-Heijboer H van den Ouweland A Klijn J Wasielewski M de Snoo A Oldenburg R Hollestelle A Houben M Crepin E van Veghel-Plandsoen M Elstrodt F van Duijn C Bartels C Meijers C Schutte M McGuffog L Thompson D Easton D Sodha N Seal S Barfoot R Mangion J Chang-Claude J Eccles D Eeles R Evans DG Houlston R Murday V Narod S Peretz T Peto J Phelan C Zhang HX Szabo C Devilee P Goldgar D Futreal PA Nathanson KL Weber B Rahman N Stratton MR;CHEK-Breast Cancer Consortium 《Nature genetics》2002,31(1):55-59
Mutations in BRCA1 and BRCA2 confer a high risk of breast and ovarian cancer, but account for only a small fraction of breast cancer susceptibility. To find additional genes conferring susceptibility to breast cancer, we analyzed CHEK2 (also known as CHK2), which encodes a cell-cycle checkpoint kinase that is implicated in DNA repair processes involving BRCA1 and p53 (refs 3,4,5). We show that CHEK2(*)1100delC, a truncating variant that abrogates the kinase activity, has a frequency of 1.1% in healthy individuals. However, this variant is present in 5.1% of individuals with breast cancer from 718 families that do not carry mutations in BRCA1 or BRCA2 (P = 0.00000003), including 13.5% of individuals from families with male breast cancer (P = 0.00015). We estimate that the CHEK2(*)1100delC variant results in an approximately twofold increase of breast cancer risk in women and a tenfold increase of risk in men. By contrast, the variant confers no increased cancer risk in carriers of BRCA1 or BRCA2 mutations. This suggests that the biological mechanisms underlying the elevated risk of breast cancer in CHEK2 mutation carriers are already subverted in carriers of BRCA1 or BRCA2 mutations, which is consistent with participation of the encoded proteins in the same pathway. 相似文献